Dr Prashant R Murumkar

@msubaroda.ac.in

Assistant Professor, Faculty of Pharmacy
The Maharaja Sayajirao University of Baroda, Vadodara

Dr Prashant R Murumkar


                  Download Compact PDF  
https://researchid.co/prashant_murumkar
Dr. Prashant Murumkar is currently working as Assistant Professor at Faculty of Pharmacy and Dy. Director, Office of Alumni Affair at The Maharaja Sayajirao University of Baroda.

Dr. Prashant is a recipient of highly prestigious “International ICMR-Young Indian Bio-medical Scientist Award” for the year 2016-17. As a part of this award Dr Prashant worked as a visiting scientist at Karolinska Institute, Division of Translational Alzheimer Neurobiology, Stockholm, Sweden.

In addition to receiving a National Doctoral Fellowship during his doctoral work, he was awarded multiple Young Scientist Travel Grants from a number of different government agencies, including Department of Science & Technology (DST), Council of Scientific and Industrial Research (CSIR), and the Indian Council of Medical Research (ICMR), facilitating the presentation of his research work at the International Conferences held in USA in the year 2008, 2009 and 2013.

EDUCATION

M.Pharm., PhD

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmaceutical Science, Drug Discovery
77

Scopus Publications

2432

Scholar Citations

26

Scholar h-index

51

Scholar i10-index

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

  • Exploring the antimicrobial landscape of carbazole derivatives through integration of computational and experimental approaches
    S Soni, K Patil, S Vishwakarma, R Yadav, PR Murumkar, R Kadu
    Discover Chemistry 3 (1), 149 , 2026
    2026
  • Research Progress on Pyrazine-based Medicinally Active Compounds: A Review
    PM Karan Joshi, Omkumar Prajapati, Sadaf Mirza, Ponam Jamwal, Miloni ...
    Mini Rev Med Chem , 2026
    2026
  • Synthesis, Characterization, and Computational Insights of Flavone Derivatives as Promising Antimicrobial Agents
    S Gavale, D Zade, K Patil, R Yadav, PR Murumkar, R Kadu
    Chemistry & Biodiversity 22 (12), e02136 , 2025
    2025
  • Exploring Oxazolidinone scaffolds for future antibiotics: synthesis and computational insights with DFT, docking, ADME and MD simulation
    S Soni, K Patil, S Gavale, S Pathan, R Yadav, PR Murumkar, R Kadu
    Journal of computer-aided molecular design 39 (1), 58 , 2025
    2025
    Citations: 2
  • One-pot synthesis and biological evaluation of some new HERα interacting indolyl-dibenzo [b, e][1, 4] diazepinone scaffolds
    AA Barot, HD Atara, VM Parmar, TP Patel, NA Raulji, UP Gohel, ...
    Journal of Molecular Structure, 144001 , 2025
    2025
    Citations: 1
  • Synergistic exploration of thiazole derivatives: Synthesis, antimicrobial activity and computational insights
    S Gavale, S Vishwakarma, S Soni, S Pathan, R Yadav, PR Murumkar, ...
    Journal of Molecular Structure 1333, 141772 , 2025
    2025
    Citations: 10
  • Exploration of Computational Approaches in Toxicity Prediction
    PR Murumkar, R Yadav, R Barot, R Shah, V Srivastava, MR Yadav
    Artificial Intelligence for Chemical Sciences, 179-207 , 2025
    2025
    Citations: 1
  • Design, synthesis, biological evaluation and molecular dynamics of some novel 3-phenylpyrazolo[1,5- a ]pyrimidine-2,7(1 H ,4 H )-dione based compounds as anti …
    M Chauhan, C Prajapati, S Mirza, R Barot, R Yadav, M Barmade, ...
    Journal of Biomolecular Structure and Dynamics 42 (17), 9031-9049 , 2024
    2024
    Citations: 3
  • The Mycobacterium tuberculosis Cell Wall: An Alluring Drug Target for Developing Newer Anti‐TB Drugs—A Perspective
    M Chauhan, R Barot, R Yadav, K Joshi, S Mirza, R Chikhale, ...
    Chemical Biology & Drug Design 104 (3), e14612 , 2024
    2024
    Citations: 18
  • Novel quinolinepiperazinyl-aryltetrazoles targeting the blood stage of Plasmodium falciparum
    MA Barmade, P Agrawal, SR Rajput, PR Murumkar, B Rana, D Sahal, ...
    RSC Medicinal Chemistry 15 (2), 572-594 , 2024
    2024
    Citations: 6
  • Approved Cholinesterase Inhibitor-Based Derivatives: Synthesis and Their Biological Evaluation
    MR Yadav, PR Murumkar, K Joshi, R Barot, R Yadav
    Natural Product-based Synthetic Drug Molecules in Alzheimer's Disease … , 2023
    2023
    Citations: 2
  • An efficient one-pot synthesis and docking studies of bioactive new antiproliferative dispiro [oxindole/acenaphthylenone‒benzofuranone] pyrrolidine scaffolds
    TR Sutariya, GC Brahmbhatt, HD Atara, NJ Parmar, RajniKant, VK Gupta, ...
    Molecular Diversity, 1-16 , 2023
    2023
    Citations: 2
  • Chromene and its Derivatives in the Treatment of SARS-COV-2 Virus Infection
    DB Ruikar, K Joshi, R Yadav, GJ Deshmukh, S Manekar, PR Murumkar
    The Role of Chromenes in Drug Discovery and Development, 164-189 , 2023
    2023
  • Role of computational modeling in drug discovery for Alzheimer’s disease
    MR Yadav, PR Murumkar, R Barot, R Yadav, K Joshi, M Chauhan
    Current trends in Computational modeling for Drug Discovery, 57-107 , 2023
    2023
    Citations: 6
  • Tuberculosis: integrated studies for a complex disease 2050
    N Rezaei, NS Hosseini, A Saghazadeh, A Fateh, A Duse, A Ahmad, ...
    Tuberculosis: Integrated Studies for a Complex Disease, 1063-1098 , 2023
    2023
    Citations: 15
  • Exploring Decaprenylphosphoryl-β- d -Ribose 2′-Epimerase 1 (DprE1): A Target for Anti-tubercular Drugs
    MR Yadav, PR Murumkar, RB Ghuge, RR Barot, M Chauhan
    Tuberculosis: Integrated Studies for a Complex Disease, 499-539 , 2023
    2023
    Citations: 5
  • Selection of suitable protein structure from protein data bank: an important step in structure-based drug design studies
    PR Murumkar, MK Sharma, P Gupta, NM Patel, MR Yadav
    Mini Reviews in Medicinal Chemistry 23 (3), 246-264 , 2023
    2023
    Citations: 18
  • Structure-based virtual screening in drug discovery
    MR Yadav, PR Murumkar, R Yadav, K Joshi
    Cheminformatics, QSAR and Machine Learning Applications for Novel Drug … , 2023
    2023
    Citations: 12
  • Design, synthesis and biological evaluation of Piperazinylanthranilamides as potential factor Xa inhibitors
    AN Khadse, HH Savsani, RV Chikhale, RB Ghuge, DR Prajapati, ...
    Journal of Molecular Structure 1270, 133974 , 2022
    2022
    Citations: 2
  • Design and synthesis of novel N -[3-(benzimidazol-2-ylamino)phenyl]amine and N -[3-(benzoxazol-2-ylamino)phenyl]amine derivatives as potential anticancer agents
    HY Kumar, PR Murumkar, BP Srinivasan, V Pawar, MR Yadav
    Molecular Diversity 26 (4), 2269-2293 , 2022
    2022
    Citations: 1

MOST CITED SCHOLAR PUBLICATIONS

  • Overview of the development of DprE1 inhibitors for combating the menace of tuberculosis
    RV Chikhale, MA Barmade, PR Murumkar, MR Yadav
    Journal of medicinal chemistry 61 (19), 8563-8593 , 2018
    2018
    Citations: 163
  • Current perspective of TACE inhibitors: a review
    S DasGupta, PR Murumkar, R Giridhar, MR Yadav
    Bioorganic & medicinal chemistry 17 (2), 444-459 , 2009
    2009
    Citations: 149
  • Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists—A perspective
    P Naik, P Murumkar, R Giridhar, MR Yadav
    Bioorganic & medicinal chemistry 18 (24), 8418-8456 , 2010
    2010
    Citations: 143
  • Unequivocal role of pyrazine ring in medicinally important compounds: A review
    P B. Miniyar, P R. Murumkar, P S. Patil, M A. Barmade, K G. Bothara
    Mini reviews in medicinal chemistry 13 (11), 1607-1625 , 2013
    2013
    Citations: 135
  • Prodrug designing of NSAIDs
    PK Halen, PR Murumkar, R Giridhar, MR Yadav
    Mini reviews in medicinal chemistry 9 (1), 124-139 , 2009
    2009
    Citations: 133
  • Medicinal chemistry perspective of fused isoxazole derivatives
    M A Barmade, P R Murumkar, M Kumar Sharma, M Ram Yadav
    Current Topics in Medicinal Chemistry 16 (26), 2863-2883 , 2016
    2016
    Citations: 128
  • Benzylpiperidine-linked diarylthiazoles as potential anti-Alzheimer’s agents: synthesis and biological evaluation
    M Shidore, J Machhi, K Shingala, P Murumkar, MK Sharma, N Agrawal, ...
    Journal of medicinal chemistry 59 (12), 5823-5846 , 2016
    2016
    Citations: 123
  • Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists
    MK Sharma, PR Murumkar, AM Kanhed, R Giridhar, MR Yadav
    European journal of medicinal chemistry 79, 298-339 , 2014
    2014
    Citations: 79
  • Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer
    MR Yadav, MA Barmade, RS Tamboli, PR Murumkar
    European journal of medicinal chemistry 105, 1-38 , 2015
    2015
    Citations: 78
  • Current and emerging direct oral anticoagulants: state-of-the-art
    G Lippi, R Gosselin, EJ Favaloro
    Seminars in thrombosis and hemostasis 45 (05), 490-501 , 2019
    2019
    Citations: 76
  • DMSO: a mixed-competitive inhibitor of human acetylcholinesterase
    A Kumar, T Darreh-Shori
    ACS chemical neuroscience 8 (12), 2618-2625 , 2017
    2017
    Citations: 73
  • Novel TACE inhibitors in drug discovery: a review of patented compounds
    PR Murumkar, S DasGupta, SR Chandani, R Giridhar, MR Yadav
    Expert opinion on therapeutic patents 20 (1), 31-57 , 2010
    2010
    Citations: 67
  • Contemporary developments in the discovery of selective factor Xa inhibitors: A review
    NR Patel, DV Patel, PR Murumkar, MR Yadav
    European journal of medicinal chemistry 121, 671-698 , 2016
    2016
    Citations: 60
  • Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
    TL Devale, J Parikh, P Miniyar, P Sharma, B Shrivastava, P Murumkar
    Bioorganic chemistry 70, 256-266 , 2017
    2017
    Citations: 57
  • Development of predictive pharmacophore model for in silico screening, and 3D QSAR CoMFA and CoMSIA studies for lead optimization, for designing of potent tumor necrosis factor …
    PR Murumkar, VP Zambre, MR Yadav
    Journal of computer-aided molecular design 24 (2), 143-156 , 2010
    2010
    Citations: 51
  • Studies on novel 2-imidazolidinones and tetrahydropyrimidin-2 (1H)-ones as potential TACE inhibitors: design, synthesis, molecular modeling, and preliminary biological evaluation
    S DasGupta, PR Murumkar, R Giridhar, MR Yadav
    Bioorganic & medicinal chemistry 17 (10), 3604-3617 , 2009
    2009
    Citations: 48
  • Novel multitarget directed triazinoindole derivatives as anti-Alzheimer agents
    DV Patel, NR Patel, AM Kanhed, SP Patel, A Sinha, DD Kansara, ...
    ACS chemical neuroscience 10 (8), 3635-3661 , 2019
    2019
    Citations: 44
  • Development of Predictive 3D‐QSAR CoMFA and CoMSIA Models for β‐aminohydroxamic Acid‐Derived Tumor Necrosis Factor‐α Converting Enzyme Inhibitors
    PR Murumkar, SD Gupta, VP Zambre, R Giridhar, MR Yadav
    Chemical Biology & Drug Design 73 (1), 97-107 , 2009
    2009
    Citations: 40
  • Structural investigations of acridine derivatives by CoMFA and CoMSIA reveal novel insight into their structures toward DNA G-quadruplex mediated telomerase inhibition and …
    VP Zambre, PR Murumkar, R Giridhar, MR Yadav
    Journal of chemical information and modeling 49 (5), 1298-1311 , 2009
    2009
    Citations: 39
  • Recent developments and strategies for the discovery of TACE inhibitors
    PR Murumkar, RB Ghuge, M Chauhan, RR Barot, S Sorathiya, ...
    Expert Opinion on Drug Discovery 15 (7), 779-801 , 2020
    2020
    Citations: 37